Eating Disorders Clinical and Research Program
Boston, Massachusetts, 02139, United States
NCT Number: NCT05954728
This study is a randomized controlledlinical trial, assessing the efficacy of cognitive- behavioral therapy (CBT-AR) and nutrition counseling for avoidant/restrictive food intake disorder (ARFID) for children and adolescents (ages 10-18 years).
Looking for future studies?
Notify Me10 year–18 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02139, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CBT-AR is a four-stage modular treatment for ARFID delivered by a mental health clinician. The four stages include: 1) Psychoeducation and early change; 2) Treatment planning; 3) Addressing maintaining mechanisms; and 4) Relapse prevention. For participants ages 10-15 years, patients/guardians attend the sessions. For patients ages 16 and up, the therapy is individual.
Nutrition counseling will be provided by skilled registered dietitians at the MGH Translational and Clinical Research Center (TCRC). Sessions focus on the foods necessary for a healthy diet, how to meet nutritional needs, how to incorporate healthy exercise, and support for making these changes. For participants ages 10-15 years, patients/guardians attend the sessions. For patients ages 16 and up, the therapy is individual.
Time frame: Change from baseline food neophobia measured at pre-treatment to after each weekly session of treatment and after the complete 15 weeks of treatment measured at post-treatment
Validated 6-item version of the Food Neophobia Scale used to assess food neophobia on a scale from 1 to 7, with higher scores indicating higher levels of food neophobia. The lowest score possible is 7, indicating low food neophobia, and highest score possible is 42, indicating high food neophobia.
Time frame: Change from baseline neural activation in response to food cues measured at pre-treatment to after 15 weeks of treatment measured at post-treatment
Used to measure neural activation in response to food cues. Higher scores indicate higher neural activation. There is no minimum or maximum for this measure.
Time frame: Change from baseline measured at pre-treatment to after 15 weeks of treatment measured at post-treatment
A revised version of the General Nutrition Knowledge Questionnaire (GNKQ) used to evaluate knowledge of nutrition. Scores are gathered through a series of multiple-choice questions. The lowest score possible is 0, indicating low knowledge of nutrition, and the highest score possible is 14, indicating high knowledge of nutrition.
Time frame: Change from baseline measured at pre-treatment to after 15 weeks of treatment measured at post-treatment
A semi-structured clinical interview assessing the symptoms and severity of Pica, ARFID, and Rumination Disorder. This interview is used to determine the presence and severity of each ARFID profile. Scores for each severity measure are assessed on a scale from 0 to 6, with higher scores indicating greater severity.
Time frame: Change from baseline measured at pre-treatment to after 15 weeks of treatment measured at post-treatment
A 32-item revised version of the Pica, ARFID, and Rumination Disorder Interview used to assess ARFID severity and presence of Pica or Rumination Disorder. Each item is assessed on a scale from 0 to 6, with higher scores indicating greater severity.
Time frame: Change from baseline measured at pre-treatment to after 15 weeks of treatment measured at post-treatment
A record of participant diet for four days prior to the Pre-Treatment Assessment and for another four days prior to the Post-Treatment Assessment. Dietary information is calculated from the recorded foods.
Time frame: Change from baseline measured at pre-treatment to after 15 weeks of treatment measured at post-treatment
A detailed recall of everything a participant has consumed during the 24 hours prior to the Pre-Treatment Assessment, and again prior to the Post-Treatment Assessment. Dietary information is calculated from the recorded foods.
Massachusetts General Hospital
Other
Cognitive and Neural Mechanisms of Cognitive-behavioral Therapy for Avoidant/Restrictive Food Intake Disorder
Acronym: COUNTERACT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06463470
Avoidant Restrictive Food Intake Disorder, Avoidant/Restrictive Food Intake Disorder (ARFID)
Melbourne, Victoria, Australia
View Trial DetailsNCT02963220
Avoidant Restrictive Food Intake Disorder, Avoidant/Restrictive Food Intake Disorder (ARFID)
Boston, Massachusetts, United States
View Trial DetailsNCT06898177
Avoidant Restrictive Food Intake Disorder, Avoidant/Restrictive Food Intake Disorder (ARFID)
Boston, Massachusetts, United States
View Trial DetailsNCT07641205
Avoidant Restrictive Food Intake Disorder, Avoidant/Restrictive Food Intake Disorder (ARFID)
Boston, Massachusetts, United States
View Trial Details